| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary J Vestbo, SS Hurd, AG Agustí, PW Jones, C Vogelmeier, A Anzueto, ... American journal of respiratory and critical care medicine 187 (4), 347-365, 2013 | 6803 | 2013 |
| Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper BR Celli, W MacNee, A Agusti, A Anzueto, B Berg, AS Buist, ... European Respiratory Journal 23 (6), 932-946, 2004 | 6728 | 2004 |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary CF Vogelmeier, GJ Criner, FJ Martinez, A Anzueto, PJ Barnes, ... American journal of respiratory and critical care medicine 195 (5), 557-582, 2017 | 5026 | 2017 |
| Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease PMA Calverley, JA Anderson, B Celli, GT Ferguson, C Jenkins, PW Jones, ... New England Journal of Medicine 356 (8), 775-789, 2007 | 4482 | 2007 |
| Susceptibility to exacerbation in COPD JR Hurst, A Anzueto, J Vestbo The Lancet Respiratory Medicine 5 (9), e29, 2017 | 3580 | 2017 |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019 D Singh, A Agusti, A Anzueto, PJ Barnes, J Bourbeau, BR Celli, GJ Criner, ... European Respiratory Journal 53 (5), 2019 | 1802 | 2019 |
| Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial P Calverley, R Pauwels, J Vestbo, P Jones, N Pride, A Gulsvik, ... The Lancet 361 (9356), 449-456, 2003 | 1670 | 2003 |
| A 15-year follow-up study of ventilatory function in adults with asthma P Lange, J Parner, J Vestbo, P Schnohr, G Jensen New England Journal of Medicine 339 (17), 1194-1200, 1998 | 1630 | 1998 |
| Characterisation of COPD heterogeneity in the ECLIPSE cohort A Agusti, PMA Calverley, B Celli, HO Coxson, LD Edwards, DA Lomas, ... Respiratory research 11, 1-14, 2010 | 1599 | 2010 |
| Chronic obstructive pulmonary disease phenotypes: the future of COPD MLK Han, A Agusti, PM Calverley, BR Celli, G Criner, JL Curtis, LM Fabbri, ... American journal of respiratory and critical care medicine 182 (5), 598-604, 2010 | 1517 | 2010 |
| Prognostic value of nutritional status in chronic obstructive pulmonary disease C Landbo, EVA Prescott, P Lange, J VESTBO, TP Almdal American journal of respiratory and critical care medicine 160 (6), 1856-1861, 1999 | 1507 | 1999 |
| Lung-function trajectories leading to chronic obstructive pulmonary disease P Lange, B Celli, A Agustí, G Boje Jensen, M Divo, R Faner, S Guerra, ... New England Journal of Medicine 373 (2), 111-122, 2015 | 1282 | 2015 |
| Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial J Vestbo, T Søorensen, P Lange, A Brix, P Torre, K Viskum The Lancet 353 (9167), 1819-1823, 1999 | 1166 | 1999 |
| Changes in forced expiratory volume in 1 second over time in COPD J Vestbo, LD Edwards, PD Scanlon, JC Yates, A Agusti, P Bakke, ... New England Journal of Medicine 365 (13), 1184-1192, 2011 | 1142 | 2011 |
| Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study BR Celli, NE Thomas, JA Anderson, GT Ferguson, CR Jenkins, PW Jones, ... American journal of respiratory and critical care medicine 178 (4), 332-338, 2008 | 1068 | 2008 |
| Indacaterol–glycopyrronium versus salmeterol–fluticasone for COPD JA Wedzicha, D Banerji, KR Chapman, J Vestbo, N Roche, RT Ayers, ... New England Journal of Medicine 374 (23), 2222-2234, 2016 | 1050 | 2016 |
| Smoking and risk of myocardial infarction in women and men: longitudinal population study E Prescott, M Hippe, P Schnohr, HO Hein, J Vestbo Bmj 316 (7137), 1043, 1998 | 996 | 1998 |
| Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype A Agustí, LD Edwards, SI Rennard, W MacNee, R Tal-Singer, BE Miller, ... PloS one 7 (5), e37483, 2012 | 992 | 2012 |
| Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. J Vestbo, EVA Prescott, P Lange American journal of respiratory and critical care medicine 153 (5), 1530-1535, 1996 | 979 | 1996 |
| Treatable traits: toward precision medicine of chronic airway diseases A Agusti, E Bel, M Thomas, C Vogelmeier, G Brusselle, S Holgate, ... European Respiratory Journal 47 (2), 410-419, 2016 | 947 | 2016 |
